BMC Cancer

Proceedings of the 3rd International Genomic Medicine Conference: cancer

Proceedings

Publication of this supplement has been supported by the Centre of Excellence in Genomic Medicine Research. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editor declares that they have no competing interests.

Jeddah, Saudi Arabia

30 November - 3 December 2015

Edited by Muhammad Abu-Elmagd.

RESEARCH ARTICLE

Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia

Renal cell carcinoma (RCC) is a seventh ranked malignancy with poor prognosis. RCC is lethal at metastatic stage as it does not respond to conventional systemic treatments, and there is an urgent need to find ...

Sajjad Karim, Jaudah A. Al-Maghrabi, Hasan M. A. Farsi, Ahmad J. Al-Sayyad, Hans-Juergen Schulten, Abdelbaset Buhmeida, Zeenat Mirza, Alaa A. Al-boogmi, Fai T. Ashgan, Manal M. Shabaad, Hend F. NourEldin, Khalid B. M. Al-Ghamdi, Adel Abuzenadah, Adeel G. A. Chaudhary and Mohammed H. Al-Qahtani

BMC Cancer 2016 16(Suppl 2):741

Published on: 30 September 2016
- Full Text
- PDF
REVIEW

In vitro models of cancer stem cells and clinical applications

Cancer cells, stem cells and cancer stem cells have for a long time played a significant role in the biomedical sciences. Though cancer therapy is more effective than it was a few years ago, the truth is that ...

Sara S. Franco, Karolina Szczesna, Maria S. Iliou, Mohammed Al-Qahtani, Ali Mobasheri, Julianna Kobolák and András Dinnyés

BMC Cancer 2016 16(Suppl 2):738

Published on: 30 September 2016
- Full Text
- PDF